Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung CancerSolange Peters, Tony Mok, Sophie Golding et al.|New England Journal of Medicine|2017Cited by 2.4k
Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery ElectrodesKi Tae Nam, Angela M. Belcher, Dong‐Wan Kim et al.|Science|2006Cited by 1.9k
First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung CancerAlice T. Shaw, Benjamin Solomon, Todd M. Bauer et al.|New England Journal of Medicine|2020Cited by 1.1k
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II TrialDong‐Wan Kim, D. Ross Camidge|Journal of Clinical Oncology|2017Cited by 582
Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 TrialKōichi Goto, Pasi A. Jänne, Yasushi Goto et al.|Journal of Clinical Oncology|2023Cited by 293